Introducing "Precision Addiction Management (PAM<sup>®</sup>)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America.

Blum, K; Modestino, E J; Lott, L; Siwicki, D; Baron, D; Howeedy, A; Badgaiyan, R D

Introducing "Precision Addiction Management (PAM^®)" as an Adjunctive Genetic Guided Therapy for Abusable Drugs in America.

Blum, K; Modestino, E J; Lott, L; Siwicki, D; Baron, D; Howeedy, A; Badgaiyan, R D.

Afiliación

Blum K; Western University Health Sciences, Graduate School of Biomedical Sciences, USA.
Modestino EJ; Division of Addiction Services, Dominion Diagnostics, USA.
Lott L; Department of Precision Addiction Management, Geneus Health, USA.
Siwicki D; Division of Neurogenetic Research and Addiction Therapy, Department of Psychology, Curry College, USA.
Baron D; Department of Psychiatry, Ichan Mount Sinai School of Medicine, USA.
Howeedy A; Department of Precision Addiction Management, Geneus Health, USA.
Badgaiyan RD; Department of Precision Addiction Management, Geneus Health, USA.

Open Access J Behav Sci Psychol ; 1(2): 1-4, 2018 Nov 20.

Article en En | MEDLINE | ID: mdl-30662982

Palabras clave

Abuse; Genetic; Pharmacogenetics; Precision addiction management; Reward deficiency syndrome

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Open Access J Behav Sci Psychol Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos